
Publikationen von Andreas H. Jacobs
Alle Typen
Zeitschriftenartikel (111)
1.
Zeitschriftenartikel
43 (10), S. 1352 - 1365 (2016)
6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis. European Journal of Neuroscience: European Neuroscience Association 2.
Zeitschriftenartikel
34 (1), S. 351 - 354 (2013)
Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease. Neurobiology of Aging 3.
Zeitschriftenartikel
40 (10), S. 1595 - 1606 (2013)
Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI. European Journal of Nuclear Medicine and Molecular Imaging 4.
Zeitschriftenartikel
11 (6), S. 516 - 527 (2012)
Volumetry of [C-11]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant glioma. Molecular Imaging 5.
Zeitschriftenartikel
53 (7), S. 1135 - 1145 (2012)
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI. Journal of Nuclear Medicine 6.
Zeitschriftenartikel
317 (20), S. 2864 - 2873 (2011)
NUMB does not impair growth and differentiation status of experimental gliomas. Experimental Cell Research 7.
Zeitschriftenartikel
10 (6), S. 453 - 459 (2011)
Imaging of non-or very subtle contrast-enhancing malignant gliomas with [ 11C]-methionine positron emission tomography. Molecular Imaging 8.
Zeitschriftenartikel
10 (3), S. 197 - 205 (2011)
Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroids. Molecular Imaging 9.
Zeitschriftenartikel
13 (3), S. 276 - 285 (2011)
Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas. Neoplasia 10.
Zeitschriftenartikel
13 (3), S. 547 - 557 (2011)
FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas. Molecular Imaging and Biology 11.
Zeitschriftenartikel
12 (6), S. 583 - 593 (2011)
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet-Oncology 12.
Zeitschriftenartikel
84 (Spec. Iss. 2), S. S168 - S178 (2011)
Specific biomarkers of receptors, pathways of inhibition and targeted therapies: Pre-clinical developments. British Journal of Radiology 13.
Zeitschriftenartikel
84 (Spec. Iss. 2), S. S179 - S195 (2011)
Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications. British Journal of Radiology 14.
Zeitschriftenartikel
29 (13), S. 1701 - 1708 (2011)
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. Journal of Clinical Oncology 15.
Zeitschriftenartikel
9 (9), S. 906 - 920 (2010)
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurology 16.
Zeitschriftenartikel
96 (2), S. 231 - 239 (2010)
[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors. Journal of Neuro-Oncology 17.
Zeitschriftenartikel
9 (1), S. 40 - 46 (2010)
Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastoma. Molecular Imaging 18.
Zeitschriftenartikel
1802 (10), S. 819 - 839 (2010)
Mouse models in neurological disorders: Applications of non-invasive imaging. Biochimica et Biophysica Acta - Molecular Basis of Disease 19.
Zeitschriftenartikel
50 (12), S. 1962 - 1968 (2009)
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine 20.
Zeitschriftenartikel
17 (8), S. 1311 - 1312 (2009)
Rapid tumor cell swelling and bursting: beware of collateral damage- Response. Molecular Therapy